These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3291457)

  • 21. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
    Dale JB
    Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of Broadly Cross-Reactive M Protein-Based Group A Streptococcal Vaccines.
    Aranha MP; Penfound TA; Salehi S; Botteaux A; Smeesters P; Dale JB; Smith JC
    J Immunol; 2021 Aug; 207(4):1138-1149. PubMed ID: 34341168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity evoked by synthetic peptides of streptococcal M proteins.
    Beachey EH
    Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199
    [No Abstract]   [Full Text] [Related]  

  • 24. Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.
    Jones KF; Manjula BN; Johnston KH; Hollingshead SK; Scott JR; Fischetti VA
    J Exp Med; 1985 Mar; 161(3):623-8. PubMed ID: 2579187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.
    Beachey EH; Tartar A; Seyer JM; Chedid L
    Proc Natl Acad Sci U S A; 1984 Apr; 81(7):2203-7. PubMed ID: 6425829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.
    Beachey EH; Seyer JM; Dale JB; Hasty DL
    J Biol Chem; 1983 Nov; 258(21):13250-7. PubMed ID: 6415061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule.
    Manjula BN; Acharya AS; Fairwell T; Fischetti VA
    J Exp Med; 1986 Jan; 163(1):129-38. PubMed ID: 2416864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin.
    Vashishtha A; Fischetti VA
    J Immunol; 1993 May; 150(10):4693-701. PubMed ID: 8482854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique and common protective epitopes among different serotypes of group A streptococcal M proteins defined with hybridoma antibodies.
    Dale JB; Beachey EH
    Infect Immun; 1984 Oct; 46(1):267-9. PubMed ID: 6207110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
    Spencer JA; Penfound T; Salehi S; Aranha MP; Wade LE; Agarwal R; Smith JC; Dale JB; Baudry J
    Vaccine; 2021 Mar; 39(12):1773-1779. PubMed ID: 33642159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli.
    Poirier TP; Kehoe MA; Dale JB; Timmis KN; Beachey EH
    Infect Immun; 1985 Apr; 48(1):198-203. PubMed ID: 2579908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant, octavalent group A streptococcal M protein vaccine.
    Dale JB; Simmons M; Chiang EC; Chiang EY
    Vaccine; 1996 Jul; 14(10):944-8. PubMed ID: 8873386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal autoimmune epitope of group A streptococci specified by M protein tetrapeptide Ile-Arg-Leu-Arg.
    Kraus W; Beachey EH
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4516-20. PubMed ID: 2454473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
    Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY
    Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein.
    Jones KF; Khan SA; Erickson BW; Hollingshead SK; Scott JR; Fischetti VA
    J Exp Med; 1986 Oct; 164(4):1226-38. PubMed ID: 2428914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective antibody against a peptide fragment of type 5 streptococcal M protein cross-reacts with human heart tissue.
    Dale JB; Beachey EH
    Trans Assoc Am Physicians; 1982; 95():286-91. PubMed ID: 7182981
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kDa protein of human myocardium and renal glomeruli.
    Kraus W; Dale JB; Beachey EH
    J Immunol; 1990 Dec; 145(12):4089-93. PubMed ID: 1701783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.